查詢結果分析
相關文獻
- A Refractory Germ Cell Tumor Successfully Treated with Bevacizumab in Combination with Paclitaxel
- Clinical Experience of Ketogenic Diet on Children with Refractory Epilepsy
- 臺灣紅豆杉天然母樹枝葉紫杉醇類含量的變異與選種價值
- 紫杉醇對婦女癌症之治療
- 附子瀉心湯在兒科臨床推廣應用經驗介紹
- 腹瀉導致遲發型新生兒出血性疾病併發顱內出血:一病例報告
- Clinical Experience with the Peritoneovenous Shunt for Intractable Ascites
- 太平洋紫杉醇Taxol臨床運用與護理
- Is Ascites Ultrafiltration Superior to Total Paracentesis for Tense Ascites?: Effect on Protein Conservation
- Mixed Germ Cell Tumor Arising in Complete Androgen Insensitivity Syndrome, Associated with Mullerian Structures
頁籤選單縮合
題 名 | A Refractory Germ Cell Tumor Successfully Treated with Bevacizumab in Combination with Paclitaxel=癌思停合併紫杉醇治療頑固性生殖細胞腫瘤 |
---|---|
作 者 | 連銘渝; 廖裕民; 葉士芃; 邱昌芳; 白禮源; | 書刊名 | 臺灣癌症醫學雜誌 |
卷 期 | 29:3 2013.09[民102.09] |
頁 次 | 頁131-134 |
分類號 | 417.3 |
關鍵詞 | 生殖細胞腫瘤; 頑固性; 紫杉醇; 癌思停; Germ cell tumor; Paclitaxel; Bevacizumab; Refractory; |
語 文 | 英文(English) |
中文摘要 | 在包含順鉑的化療後復發或對其有抗藥性的生殖細胞腫瘤病人,預後很差。至今仍 沒有標準的救援治療。在此,我們提出一位女性生殖細胞腫瘤病患對多種化學治療處方 皆無反應。此位病人在使用每週注射紫杉醇合併低劑量癌思停後腫瘤反應極佳,無疾病 進展存活時間達到 17 個月。文內將討論血管生成和抗血管生成治療在生殖細胞腫瘤上的 角色。我們認為對於有抗藥性的生殖細胞腫瘤,紫杉醇結合低劑量癌思停是一個毒性小, 可忍受且反應良好,值得繼續研究的化療處方。 |
英文摘要 | Patients with germ cell tumors relapsing from or refractory to cisplatin-based chemotherapy have a poor prognosis. To date, there is no standard salvage therapy in this scenario. We report on a heavily treated patient with germ cell tumor refractory to cisplatin-based chemotherapy and the combination of gemcitabine plus oxaliplatin. The patient had a good response to low dose of bevacizumab in combination with weekly paclitaxel with a progression-free interval of 17 months. The role of angiogenesis and anti-angiogenic therapy in germ cell tumor is discussed. We suggest that the combination of bevacizumab and paclitaxel is feasible, well tolerated, and merits further clinical investigation. |
本系統中英文摘要資訊取自各篇刊載內容。